Article
Role of homologous recombination in trabectedin-induced DNA damage.
European journal of cancer (Oxford, England : 1990) - 1 Mar 2008
Tavecchio M, Simone M, Erba E, Chiolo I, Liberi G, Foiani M, D'Incalci M, Damia G
Abstract excerpt
Trabectedin (ET-743, Yondelis) is a natural marine compound with antitumour activity currently undergoing phase II/III clinical trials. The mechanism of the drug's action is still to be defined, even though it has been clearly demonstrated the key role of Nucleotide Excision Repair (NER). To get further insights into the drug's mode of action, we studied the involvement of the DNA-double strand break repair...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
